title: Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrity.
abstract: High-content flow (HCF) screening systems, such as the iQue Screener and HTFC Screening System from IntelliCyt, have facilitated the implementation of flow cytometry assays for high-throughput screening. HCF screening systems enable the use of smaller sample volumes and multiplexed assays to simultaneously assess different cellular parameters from a single well. This becomes invaluable when working with cells or compounds that are available in limited quantities or when conducting large-scale screens. When assays can be miniaturized to a 384- or 1536-well microplate format, it is possible to implement dose-response-based high-throughput screens, also known as quantitative HTS or qHTS. This article describes how qHTS at the new National Center for Advancing Translational Science (NCATS) has been systematically coupled with the HTFC Screening System and Multimetric Apoptosis Screening Kit from IntelliCyt to biologically validate active compounds from primary cell proliferation screens using a model of diffuse large B cell lymphoma (DLBCL).
authors.affiliation: Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.
authors.forename: Lesley A
authors.initials: LA
authors.lastname: Mathews
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Keller
authors.forename: Crystal
authors.initials: C
authors.lastname: McKnight
authors.forename: Sam
authors.initials: S
authors.lastname: Michael
authors.forename: Paul
authors.initials: P
authors.lastname: Shinn
authors.forename: Dongbo
authors.initials: D
authors.lastname: Liu
authors.forename: Louis M
authors.initials: LM
authors.lastname: Staudt
authors.forename: Craig J
authors.initials: CJ
authors.lastname: Thomas
authors.forename: Marc
authors.initials: M
authors.lastname: Ferrer
mesh_terms: D017304:Annexin A5 / Q000096:biosynthesis*; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000378:metabolism*; D053179:Caspase 7 / Q000378:metabolism*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects*; D005434:Flow Cytometry; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D051336:Mitochondrial Membranes / Q000187:drug effects*
chemical_list: D017304:Annexin A5; D053148:Caspase 3; D053179:Caspase 7
keywords: annexin V; cell viability; high-content flow (HCF); lcaspase 3/7; mitochondrial membrane integrity; quantitative high-throughput screening (qHTS)